The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지

Analysis of Clinical Characteristics for 899 Cancer Patients Treated at an Oriental Hospital

한방병원에서 치료받은 암환자 899명에 대한 임상적 특성 분석

  • Jeong, Tae-Young (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Lee, Yeon-Weol (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Cho, Chong-Kwan (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Yoo, Hwa-Seung (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University)
  • 정태영 (대전대학교 둔산한방병원 동서암센터) ;
  • 이연월 (대전대학교 둔산한방병원 동서암센터) ;
  • 조종관 (대전대학교 둔산한방병원 동서암센터) ;
  • 유화승 (대전대학교 둔산한방병원 동서암센터)
  • Published : 2010.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : This study was aimed to obtain epidemiological information of cancer patients treated with Oriental medicine. Methods :The medical records of 899 cancer patients treated at the East-West Cancer Center of Dunsan Oriental Hospital from January to December 2008 were analyzed. Careful investigations were done by categorizing these patients by their sex, origin, stage, treatment duration, conventional treatment type, etc. Results : 61.7% of the patients had stage IV tumor. 53.1% of patients visited Oriental hospital for combination treatment with conventional medicine. In the tumor origin, lung cancer showed the largest proportion (21.6%). Of the two genders, lung cancer was the most frequent cause (31%) in male patients, and breast cancer in females (21.2%). In inpatients, thyroid cancer resulted in the highest percentage (24.0%). Lung, colon, stomach cancer patients were mostly in stage III or IV. Thyroid cancer patients were mostly in stage I. Conclusions : This study presented the characteristics of cancer patients treated by Oriental medicine. Based on this study, further advanced study of Oriental medical cancer treatments is needed.

Keywords

References

  1. National Cancer Information Center. National cancer incidence in 2006-2007. 2009. Available at: URL:http://www.cancer.go.kr/cms/statics/ incidence/index.html. Accessed January 15, 2010.
  2. Korean Statistical Information Service. Statistics about causes of death in 2008. 2009. Available at : URL:http://www.kosis.kr/OLAPN/Analysis/ stat_OLAP.jsp?tbl_id=DT_1B34E13&org_i d=101&vwcd=MT_ZTITLE&path=%BA%B 8%B0%C7%A1%A4%BB%E7%C8%B8%A1% A4%BA%B9%C1%F6. Accessed January 15, 2010.
  3. 조종관, 유화승. 암 전이 재발을 막아주는 한방신치료 전략. 서울: 가림출판사; 2009, p. 26-35.
  4. Ostermann T, Raak C, Bussing A. Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review. BMC Cancer. 2009;18(9):451.
  5. Diehl V. The bridge between patient and doctor: the shift from CAM to integrative medicine. Hematology Am Soc Hematol Educ Program. 2009:320-325.
  6. Wesa K, Gubili J, Cassileth B. Integrative oncology: complementary therapies for cancer survivors. Hematol Oncol Clin North Am. 2008;22(2):343-353. https://doi.org/10.1016/j.hoc.2008.02.002
  7. Deng G. Integrative Cancer Care in a US Academic Cancer Centre: The Memorial Sloan-Kettering Experience. Curr Oncol. 2008;15(S2):68-71.
  8. Kim JS, Yoo HS, Cho CK, Son CG, Cho JH, Lee YW. Study on level of evidence and recommendations of complementary and alternative medicine for cancer by using natural standard methodology. Korean J. Orient.Int. Med. 2008;29(1):160-176.
  9. Moon BH, Lee WC. Studies on the anti-cancer activity of Chaga mushroom extract. J Korean Oriental Med. 2009;30(4):1-12.
  10. Lee DE, Lee SY, Kim JS, Cho CK, Yoo HS, Choi SJ. Antitumor effect of Hang-Am-Dan (HAD) and its ingredients on Calu6 and MCF-7 human cancer cell lines. J Korean Oriental Med. 2009;30(5):50-60.
  11. Son GJ, Park YC. Cytotoxic effect of Iljoongeum on human prostate cancer cells. Korean J. Orient.Int. Med. 2008;29(1):25-31.
  12. Park SC, Yoo HS, Cho CK, Lee YW. Recent experimental tendency for herbal medicines treating lung cancer in South Korea. J of Kor. Traditional Oncology. 2008;13(1):43-54.
  13. Park JS, Yoo HS, Lee YW, Cho JH, Son CG, Cho CK. Wheel Balance Cancer Therapy in the Treatment of Metastatic Gastric Carcinoma : A Retrospective Analysis of 62 patients. Korean J. Orient. Int. Med. 2007;28(3):531-533.
  14. Park BK, Yoo HS, Lee YW, Han SS, Cho JH, Son CG, et al. Retrospective cohort analysis for lung cancer patients treated with Wheel Balance Therapy (WBT). Korean J. Orient.Int. Med. 2008;29s:45-56.
  15. Jeong TY, Cho JH, Lee JH, Cho CK, Yoo HS, Son CG. Study on 110 cancer patients treated by combination of oriental and conventional treatment. J Korean Oriental Med. 2009;30(1): 128-136.
  16. Jeong TY, Park BK, Cho JH, Son CG. Clinical analysis of 312 patients with hepatobiliary cancer in oriental hospital. J Korean Orient Med. 2009;30(5):163-173.
  17. Park BK, Lee JH, Cho CK, Shin HK, Eom SK, Yoo HS. Systemic review of clinical studies about oriental medical treatment of cancer in Korea. Korean J. Orient.Int. Med. 2008;29(4): 1061-1074.
  18. Kim JS, Yoo HS, Cho CK, Lee YW. Analyisis of current use of oriental medicine in South Korea for cancer treatment. Korean J.Orient.Int. Med. 2009;29s:271-279.
  19. East-West Cancer Center. Wheel Balance Therapy - Oriental medical therapy. 2009. Available at: URL:http://www.ewcc.or.kr/s03/s03_04_04_ 01.htm?g1=s03&dte=s03_01&p=20. Accessed January 15, 2010.
  20. Yoo HS, Lee YY, Song KC, Choi BL, Seo SH, Choi WJ, et al. A case of hepatoma patients with lungs and brain metastasis. J. of Kor. Oriental Oncology. 2001;7(1):138.
  21. East-West Cancer Center. Introduction of East -West Cancer Center - Mass media reports. 2008. Available at: URL:http://www.ewcc.or. kr/bbs/bbs /board.php?bo_table=s05_01&wr_id =16. Accessed January 15, 2010.
  22. Choi IJ. Gastric cancer screening and diagnosis.Korean J Gastroenterol. 2009;54:67-76. https://doi.org/10.4166/kjg.2009.54.2.67
  23. Ahn HY, Park YJ. Incidence and clinical characteristics of thyroid cancer in Korea. Korean J Med. 2009;77(5):537-542.
  24. Kim WB. Management guidelines for patients with thyroid cancer. Korean J Med. 2009;77(5): 552-558.
  25. Han SH, Yang KH, Bae BN, Kim KH, Kim HJ, Kim YD, et al. Comparison of Tamoxifen and Toremifene as Adjuvant treatment in node -negative postmenopausal breast cancer. J Korean Surg Soc. 2002;63:283-286.
  26. National Cancer Center. Side effect of breast cancer therapies. 2007. Available at: URL:http: //www.ncc.re.kr/index.jsp. Accessed January 15, 2010.
  27. 보건복지가족부. 한,의,치의 협진제도 추진방안.2009. Available at: URL:http://www.mw.go.kr/front /al/sal0301vw.jsp?PAR_MENU_ID=04&M ENU_ID=0403&BOARD_ID=140&BOAR D_FLAG=00&CONT_SEQ=220371&page= 1 Accessed January 15, 2010.